103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB3428
 
Introduced , by Rep. Diane Blair-Sherlock
 
SYNOPSIS AS INTRODUCED:






105 ILCS 5/22-30

 Amends the General Provisions Article of the School Code. Provides that a school district, public school, charter school, or nonpublic school shall (instead of may) maintain a supply of an opioid antagonist in any secure location where an individual may have an opioid overdose. Makes a conforming change.



LRB103 29807 RJT 56214 b


STATE MANDATES ACT MAY REQUIRE REIMBURSEMENT
MAY APPLY

 
 
A BILL FOR
 


HB3428LRB103 29807 RJT 56214 b



1 AN ACT concerning education.


2 Be it enacted by the People of the State of Illinois,

3represented in the General Assembly:



4 Section 5. The School Code is amended by changing Section 
522-30 as follows:



6 (105 ILCS 5/22-30)



7 Sec. 22-30. Self-administration and self-carry of asthma 
8medication and epinephrine injectors; administration of 
9undesignated epinephrine injectors; administration of an 
10opioid antagonist; administration of undesignated asthma 
11medication; asthma episode emergency response protocol.

12 (a) For the purpose of this Section only, the following 
13terms shall have the meanings set forth below:

14 "Asthma action plan" means a written plan developed with a 
15pupil's medical provider to help control the pupil's asthma. 
16The goal of an asthma action plan is to reduce or prevent 
17flare-ups and emergency department visits through day-to-day 
18management and to serve as a student-specific document to be 
19referenced in the event of an asthma episode.
20 "Asthma episode emergency response protocol" means a 
21procedure to provide assistance to a pupil experiencing 
22symptoms of wheezing, coughing, shortness of breath, chest 
23tightness, or breathing difficulty.
 
 
HB3428- 2 -LRB103 29807 RJT 56214 b


1 "Epinephrine injector" includes an auto-injector approved 
2by the United States Food and Drug Administration for the 
3administration of epinephrine and a pre-filled syringe 
4approved by the United States Food and Drug Administration and 
5used for the administration of epinephrine that contains a 
6pre-measured dose of epinephrine that is equivalent to the 
7dosages used in an auto-injector. 
8 "Asthma medication" means quick-relief asthma medication, 
9including albuterol or other short-acting bronchodilators, 
10that is approved by the United States Food and Drug 
11Administration for the treatment of respiratory distress. 
12"Asthma medication" includes medication delivered through a 
13device, including a metered dose inhaler with a reusable or 
14disposable spacer or a nebulizer with a mouthpiece or mask.

15 "Opioid antagonist" means a drug that binds to opioid 
16receptors and blocks or inhibits the effect of opioids acting 
17on those receptors, including, but not limited to, naloxone 
18hydrochloride or any other similarly acting drug approved by 
19the U.S. Food and Drug Administration. 
20 "Respiratory distress" means the perceived or actual 
21presence of wheezing, coughing, shortness of breath, chest 
22tightness, breathing difficulty, or any other symptoms 
23consistent with asthma. Respiratory distress may be 
24categorized as "mild-to-moderate" or "severe". 
25 "School nurse" means a registered nurse working in a 
26school with or without licensure endorsed in school nursing. 
 
 
HB3428- 3 -LRB103 29807 RJT 56214 b


1 "Self-administration" means a pupil's discretionary use of 
2his or
her prescribed asthma medication or epinephrine 
3injector.

4 "Self-carry" means a pupil's ability to carry his or her 
5prescribed asthma medication or epinephrine injector.
6 "Standing protocol" may be issued by (i) a physician 
7licensed to practice medicine in all its branches, (ii) a 
8licensed physician assistant with prescriptive authority, or 
9(iii) a licensed advanced practice registered nurse with 
10prescriptive authority. 
11 "Trained personnel" means any school employee or volunteer 
12personnel authorized in Sections 10-22.34, 10-22.34a, and 
1310-22.34b of this Code who has completed training under 
14subsection (g) of this Section to recognize and respond to 
15anaphylaxis, an opioid overdose, or respiratory distress.
16 "Undesignated asthma medication" means asthma medication 
17prescribed in the name of a school district, public school, 
18charter school, or nonpublic school.
19 "Undesignated epinephrine injector" means an epinephrine 
20injector prescribed in the name of a school district, public 
21school, charter school, or nonpublic school. 
22 (b) A school, whether public, charter, or nonpublic, must 
23permit the
self-administration and self-carry of asthma

24medication by a pupil with asthma or the self-administration 
25and self-carry of an epinephrine injector by a pupil, provided 
26that:

 
 
HB3428- 4 -LRB103 29807 RJT 56214 b


1  (1) the parents or
guardians of the pupil provide to 
2 the school (i) written
authorization from the parents or 
3 guardians for (A) the self-administration and self-carry 
4 of asthma medication or (B) the self-carry of asthma 
5 medication or (ii) for (A) the self-administration and 
6 self-carry of an epinephrine injector or (B) the 
7 self-carry of an epinephrine injector, written 
8 authorization from the pupil's physician, physician 
9 assistant, or advanced practice registered nurse; and

10  (2) the
parents or guardians of the pupil provide to 
11 the school (i) the prescription label, which must contain 
12 the name of the asthma medication, the prescribed dosage, 
13 and the time at which or circumstances under which the 
14 asthma medication is to be administered, or (ii) for the 
15 self-administration or self-carry of an epinephrine 
16 injector, a
written
statement from the pupil's physician, 
17 physician assistant, or advanced practice registered
nurse 
18 containing
the following information:

19   (A) the name and purpose of the epinephrine 
20 injector;

21   (B) the prescribed dosage; and

22   (C) the time or times at which or the special 
23 circumstances
under which the epinephrine injector is 
24 to be administered.

25The information provided shall be kept on file in the office of 
26the school
nurse or,
in the absence of a school nurse, the 
 
 
HB3428- 5 -LRB103 29807 RJT 56214 b


1school's administrator.

2 (b-5) A school district, public school, charter school, or 
3nonpublic school may authorize the provision of a 
4student-specific or undesignated epinephrine injector to a 
5student or any personnel authorized under a student's 
6Individual Health Care Action Plan, Illinois Food Allergy 
7Emergency Action Plan and Treatment Authorization Form, or 
8plan pursuant to Section 504 of the federal Rehabilitation Act 
9of 1973 to administer an epinephrine injector to the student, 
10that meets the student's prescription on file.
11 (b-10) The school district, public school, charter school, 
12or nonpublic school may authorize a school nurse or trained 
13personnel to do the following: (i) provide an undesignated 
14epinephrine injector to a student for self-administration only 
15or any personnel authorized under a student's Individual 
16Health Care Action Plan, Illinois Food Allergy Emergency 
17Action Plan and Treatment Authorization Form, plan pursuant to 
18Section 504 of the federal Rehabilitation Act of 1973, or 
19individualized education program plan to administer to the 
20student that meets the student's prescription on file; (ii) 
21administer an undesignated epinephrine injector that meets the 
22prescription on file to any student who has an Individual 
23Health Care Action Plan, Illinois Food Allergy Emergency 
24Action Plan and Treatment Authorization Form, plan pursuant to 
25Section 504 of the federal Rehabilitation Act of 1973, or 
26individualized education program plan that authorizes the use 
 
 
HB3428- 6 -LRB103 29807 RJT 56214 b


1of an epinephrine injector; (iii) administer an undesignated 
2epinephrine injector to any person that the school nurse or 
3trained personnel in good faith believes is having an 
4anaphylactic reaction; (iv) administer an opioid antagonist to 
5any person that the school nurse or trained personnel in good 
6faith believes is having an opioid overdose; (v) provide 
7undesignated asthma medication to a student for 
8self-administration only or to any personnel authorized under 
9a student's Individual Health Care Action Plan or asthma 
10action plan, plan pursuant to Section 504 of the federal 
11Rehabilitation Act of 1973, or individualized education 
12program plan to administer to the student that meets the 
13student's prescription on file; (vi) administer undesignated 
14asthma medication that meets the prescription on file to any 
15student who has an Individual Health Care Action Plan or 
16asthma action plan, plan pursuant to Section 504 of the 
17federal Rehabilitation Act of 1973, or individualized 
18education program plan that authorizes the use of asthma 
19medication; and (vii) administer undesignated asthma 
20medication to any person that the school nurse or trained 
21personnel believes in good faith is having respiratory 
22distress. 
23 (c) The school district, public school, charter school, or 
24nonpublic school must inform the parents or
guardians of the

25pupil, in writing, that the school district, public school, 
26charter school, or nonpublic school and its
employees and

 
 
HB3428- 7 -LRB103 29807 RJT 56214 b


1agents, including a physician, physician assistant, or 
2advanced practice registered nurse providing standing protocol 
3and a prescription for school epinephrine injectors, an opioid 
4antagonist, or undesignated asthma medication,
are to incur no 
5liability or professional discipline, except for willful and 
6wanton conduct, as a result
of any injury arising from the

7administration of asthma medication, an epinephrine injector, 
8or an opioid antagonist regardless of whether authorization 
9was given by the pupil's parents or guardians or by the pupil's 
10physician, physician assistant, or advanced practice 
11registered nurse. The parents or guardians
of the pupil must 
12sign a statement acknowledging that the school district, 
13public school, charter school,
or nonpublic school and its 
14employees and agents are to incur no liability, except for 
15willful and wanton
conduct, as a result of any injury arising

16from the
administration of asthma medication, an epinephrine 
17injector, or an opioid antagonist regardless of whether 
18authorization was given by the pupil's parents or guardians or 
19by the pupil's physician, physician assistant, or advanced 
20practice registered nurse and that the parents or
guardians 
21must indemnify and hold harmless the school district, public 
22school, charter school, or nonpublic
school and
its
employees 
23and agents against any claims, except a claim based on willful 
24and
wanton conduct, arising out of the
administration of 
25asthma medication, an epinephrine injector, or an opioid 
26antagonist regardless of whether authorization was given by 
 
 
HB3428- 8 -LRB103 29807 RJT 56214 b


1the pupil's parents or guardians or by the pupil's physician, 
2physician assistant, or advanced practice registered nurse.
3 (c-5) When a school nurse or trained personnel administers 
4an undesignated epinephrine injector to a person whom the 
5school nurse or trained personnel in good faith believes is 
6having an anaphylactic reaction, administers an opioid 
7antagonist to a person whom the school nurse or trained 
8personnel in good faith believes is having an opioid overdose, 
9or administers undesignated asthma medication to a person whom 
10the school nurse or trained personnel in good faith believes 
11is having respiratory distress, notwithstanding the lack of 
12notice to the parents or guardians of the pupil or the absence 
13of the parents or guardians signed statement acknowledging no 
14liability, except for willful and wanton conduct, the school 
15district, public school, charter school, or nonpublic school 
16and its employees and agents, and a physician, a physician 
17assistant, or an advanced practice registered nurse providing 
18standing protocol and a prescription for undesignated 
19epinephrine injectors, an opioid antagonist, or undesignated 
20asthma medication, are to incur no liability or professional 
21discipline, except for willful and wanton conduct, as a result 
22of any injury arising from the use of an undesignated 
23epinephrine injector, the use of an opioid antagonist, or the 
24use of undesignated asthma medication, regardless of whether 
25authorization was given by the pupil's parents or guardians or 
26by the pupil's physician, physician assistant, or advanced 
 
 
HB3428- 9 -LRB103 29807 RJT 56214 b


1practice registered nurse.

2 (d) The permission for self-administration and self-carry 
3of asthma medication or the self-administration and self-carry 
4of an epinephrine injector is effective
for the school year 
5for which it is granted and shall be renewed each
subsequent 
6school year upon fulfillment of the requirements of this

7Section.

8 (e) Provided that the requirements of this Section are 
9fulfilled, a
pupil with asthma may self-administer and 
10self-carry his or her asthma medication or a pupil may 
11self-administer and self-carry an epinephrine injector (i) 
12while in
school, (ii) while at a school-sponsored activity, 
13(iii) while under the
supervision of
school personnel, or (iv) 
14before or after normal school activities, such
as while in 
15before-school or after-school care on school-operated
property 
16or while being transported on a school bus.

17 (e-5) Provided that the requirements of this Section are 
18fulfilled, a school nurse or trained personnel may administer 
19an undesignated epinephrine injector to any person whom the 
20school nurse or trained personnel in good faith believes to be 
21having an anaphylactic reaction (i) while in school, (ii) 
22while at a school-sponsored activity, (iii) while under the 
23supervision of school personnel, or (iv) before or after 
24normal school activities, such
as while in before-school or 
25after-school care on school-operated property or while being 
26transported on a school bus. A school nurse or trained 
 
 
HB3428- 10 -LRB103 29807 RJT 56214 b


1personnel may carry undesignated epinephrine injectors on his 
2or her person while in school or at a school-sponsored 
3activity. 
4 (e-10) Provided that the requirements of this Section are 
5fulfilled, a school nurse or trained personnel may administer 
6an opioid antagonist to any person whom the school nurse or 
7trained personnel in good faith believes to be having an 
8opioid overdose (i) while in school, (ii) while at a 
9school-sponsored activity, (iii) while under the supervision 
10of school personnel, or (iv) before or after normal school 
11activities, such as while in before-school or after-school 
12care on school-operated property. A school nurse or trained 
13personnel may carry an opioid antagonist on his or her person 
14while in school or at a school-sponsored activity. 
15 (e-15) If the requirements of this Section are met, a 
16school nurse or trained personnel may administer undesignated 
17asthma medication to any person whom the school nurse or 
18trained personnel in good faith believes to be experiencing 
19respiratory distress (i) while in school, (ii) while at a 
20school-sponsored activity, (iii) while under the supervision 
21of school personnel, or (iv) before or after normal school 
22activities, including before-school or after-school care on 
23school-operated property. A school nurse or trained personnel 
24may carry undesignated asthma medication on his or her person 
25while in school or at a school-sponsored activity. 
26 (f) The school district, public school, charter school, or 
 
 
HB3428- 11 -LRB103 29807 RJT 56214 b


1nonpublic school may maintain a supply of undesignated 
2epinephrine injectors in any secure location that is 
3accessible before, during, and after school where an allergic 
4person is most at risk, including, but not limited to, 
5classrooms and lunchrooms. A physician, a physician assistant 
6who has prescriptive authority in accordance with Section 7.5 
7of the Physician Assistant Practice Act of 1987, or an 
8advanced practice registered nurse who has prescriptive 
9authority in accordance with Section 65-40 of the Nurse 
10Practice Act may prescribe undesignated epinephrine injectors 
11in the name of the school district, public school, charter 
12school, or nonpublic school to be maintained for use when 
13necessary. Any supply of epinephrine injectors shall be 
14maintained in accordance with the manufacturer's instructions.
15 The school district, public school, charter school, or 
16nonpublic school shall may maintain a supply of an opioid 
17antagonist in any secure location where an individual may have 
18an opioid overdose. A health care professional who has been 
19delegated prescriptive authority for opioid antagonists in 
20accordance with Section 5-23 of the Substance Use Disorder Act 
21shall may prescribe opioid antagonists in the name of the 
22school district, public school, charter school, or nonpublic 
23school, to be maintained for use when necessary. Any supply of 
24opioid antagonists shall be maintained in accordance with the 
25manufacturer's instructions. 
26 The school district, public school, charter school, or 
 
 
HB3428- 12 -LRB103 29807 RJT 56214 b


1nonpublic school may maintain a supply of asthma medication in 
2any secure location that is accessible before, during, or 
3after school where a person is most at risk, including, but not 
4limited to, a classroom or the nurse's office. A physician, a 
5physician assistant who has prescriptive authority under 
6Section 7.5 of the Physician Assistant Practice Act of 1987, 
7or an advanced practice registered nurse who has prescriptive 
8authority under Section 65-40 of the Nurse Practice Act may 
9prescribe undesignated asthma medication in the name of the 
10school district, public school, charter school, or nonpublic 
11school to be maintained for use when necessary. Any supply of 
12undesignated asthma medication must be maintained in 
13accordance with the manufacturer's instructions. 
14 (f-3) Whichever entity initiates the process of obtaining 
15undesignated epinephrine injectors and providing training to 
16personnel for carrying and administering undesignated 
17epinephrine injectors shall pay for the costs of the 
18undesignated epinephrine injectors.
19 (f-5) Upon any administration of an epinephrine injector, 
20a school district, public school, charter school, or nonpublic 
21school must immediately activate the EMS system and notify the 
22student's parent, guardian, or emergency contact, if known.
23 Upon any administration of an opioid antagonist, a school 
24district, public school, charter school, or nonpublic school 
25must immediately activate the EMS system and notify the 
26student's parent, guardian, or emergency contact, if known. 
 
 
HB3428- 13 -LRB103 29807 RJT 56214 b


1 (f-10) Within 24 hours of the administration of an 
2undesignated epinephrine injector, a school district, public 
3school, charter school, or nonpublic school must notify the 
4physician, physician assistant, or advanced practice 
5registered nurse who provided the standing protocol and a 
6prescription for the undesignated epinephrine injector of its 
7use. 
8 Within 24 hours after the administration of an opioid 
9antagonist, a school district, public school, charter school, 
10or nonpublic school must notify the health care professional 
11who provided the prescription for the opioid antagonist of its 
12use. 
13 Within 24 hours after the administration of undesignated 
14asthma medication, a school district, public school, charter 
15school, or nonpublic school must notify the student's parent 
16or guardian or emergency contact, if known, and the physician, 
17physician assistant, or advanced practice registered nurse who 
18provided the standing protocol and a prescription for the 
19undesignated asthma medication of its use. The district or 
20school must follow up with the school nurse, if available, and 
21may, with the consent of the child's parent or guardian, 
22notify the child's health care provider of record, as 
23determined under this Section, of its use. 
24 (g) Prior to the administration of an undesignated 
25epinephrine injector, trained personnel must submit to the 
26school's administration proof of completion of a training 
 
 
HB3428- 14 -LRB103 29807 RJT 56214 b


1curriculum to recognize and respond to anaphylaxis that meets 
2the requirements of subsection (h) of this Section. Training 
3must be completed annually. The school district, public 
4school, charter school, or nonpublic school must maintain 
5records related to the training curriculum and trained 
6personnel.
7 Prior to the administration of an opioid antagonist, 
8trained personnel must submit to the school's administration 
9proof of completion of a training curriculum to recognize and 
10respond to an opioid overdose, which curriculum must meet the 
11requirements of subsection (h-5) of this Section. Training 
12must be completed annually. Trained personnel must also submit 
13to the school's administration proof of cardiopulmonary 
14resuscitation and automated external defibrillator 
15certification. The school district, public school, charter 
16school, or nonpublic school must maintain records relating to 
17the training curriculum and the trained personnel. 
18 Prior to the administration of undesignated asthma 
19medication, trained personnel must submit to the school's 
20administration proof of completion of a training curriculum to 
21recognize and respond to respiratory distress, which must meet 
22the requirements of subsection (h-10) of this Section. 
23Training must be completed annually, and the school district, 
24public school, charter school, or nonpublic school must 
25maintain records relating to the training curriculum and the 
26trained personnel. 
 
 
HB3428- 15 -LRB103 29807 RJT 56214 b


1 (h) A training curriculum to recognize and respond to 
2anaphylaxis, including the administration of an undesignated 
3epinephrine injector, may be conducted online or in person.
4 Training shall include, but is not limited to:
5  (1) how to recognize signs and symptoms of an allergic 
6 reaction, including anaphylaxis;
7  (2) how to administer an epinephrine injector; and
8  (3) a test demonstrating competency of the knowledge 
9 required to recognize anaphylaxis and administer an 
10 epinephrine injector.
11 Training may also include, but is not limited to:
12  (A) a review of high-risk areas within a school and 
13 its related facilities;
14  (B) steps to take to prevent exposure to allergens;
15  (C) emergency follow-up procedures, including the 
16 importance of calling 9-1-1 or, if 9-1-1 is not available, 
17 other local emergency medical services;
18  (D) how to respond to a student with a known allergy, 
19 as well as a student with a previously unknown allergy;
20  (E) other criteria as determined in rules adopted 
21 pursuant to this Section; and
22  (F) any policy developed by the State Board of 
23 Education under Section 2-3.190.
24 In consultation with statewide professional organizations 
25representing physicians licensed to practice medicine in all 
26of its branches, registered nurses, and school nurses, the 
 
 
HB3428- 16 -LRB103 29807 RJT 56214 b


1State Board of Education shall make available resource 
2materials consistent with criteria in this subsection (h) for 
3educating trained personnel to recognize and respond to 
4anaphylaxis. The State Board may take into consideration the 
5curriculum on this subject developed by other states, as well 
6as any other curricular materials suggested by medical experts 
7and other groups that work on life-threatening allergy issues. 
8The State Board is not required to create new resource 
9materials. The State Board shall make these resource materials 
10available on its Internet website.
11 (h-5) A training curriculum to recognize and respond to an 
12opioid overdose, including the administration of an opioid 
13antagonist, may be conducted online or in person. The training 
14must comply with any training requirements under Section 5-23 
15of the Substance Use Disorder Act and the corresponding rules. 
16It must include, but is not limited to:
17  (1) how to recognize symptoms of an opioid overdose;
18  (2) information on drug overdose prevention and 
19 recognition;
20  (3) how to perform rescue breathing and resuscitation;
21  (4) how to respond to an emergency involving an opioid 
22 overdose;
23  (5) opioid antagonist dosage and administration;
24  (6) the importance of calling 9-1-1 or, if 9-1-1 is 
25 not available, other local emergency medical services;
26  (7) care for the overdose victim after administration 
 
 
HB3428- 17 -LRB103 29807 RJT 56214 b


1 of the overdose antagonist;
2  (8) a test demonstrating competency of the knowledge 
3 required to recognize an opioid overdose and administer a 
4 dose of an opioid antagonist; and
5  (9) other criteria as determined in rules adopted 
6 pursuant to this Section. 
7 (h-10) A training curriculum to recognize and respond to 
8respiratory distress, including the administration of 
9undesignated asthma medication, may be conducted online or in 
10person. The training must include, but is not limited to:
11  (1) how to recognize symptoms of respiratory distress 
12 and how to distinguish respiratory distress from 
13 anaphylaxis;
14  (2) how to respond to an emergency involving 
15 respiratory distress;
16  (3) asthma medication dosage and administration;
17  (4) the importance of calling 9-1-1 or, if 9-1-1 is 
18 not available, other local emergency medical services;
19  (5) a test demonstrating competency of the knowledge 
20 required to recognize respiratory distress and administer 
21 asthma medication; and
22  (6) other criteria as determined in rules adopted 
23 under this Section. 
24 (i) Within 3 days after the administration of an 
25undesignated epinephrine injector by a school nurse, trained 
26personnel, or a student at a school or school-sponsored 
 
 
HB3428- 18 -LRB103 29807 RJT 56214 b


1activity, the school must report to the State Board of 
2Education in a form and manner prescribed by the State Board 
3the following information:
4  (1) age and type of person receiving epinephrine 
5 (student, staff, visitor);
6  (2) any previously known diagnosis of a severe 
7 allergy;
8  (3) trigger that precipitated allergic episode;
9  (4) location where symptoms developed;
10  (5) number of doses administered;
11  (6) type of person administering epinephrine (school 
12 nurse, trained personnel, student); and
13  (7) any other information required by the State Board.
14 If a school district, public school, charter school, or 
15nonpublic school maintains or has an independent contractor 
16providing transportation to students who maintains a supply of 
17undesignated epinephrine injectors, then the school district, 
18public school, charter school, or nonpublic school must report 
19that information to the State Board of Education upon adoption 
20or change of the policy of the school district, public school, 
21charter school, nonpublic school, or independent contractor, 
22in a manner as prescribed by the State Board. The report must 
23include the number of undesignated epinephrine injectors in 
24supply.
25 (i-5) Within 3 days after the administration of an opioid 
26antagonist by a school nurse or trained personnel, the school 
 
 
HB3428- 19 -LRB103 29807 RJT 56214 b


1must report to the State Board of Education, in a form and 
2manner prescribed by the State Board, the following 
3information:
4  (1) the age and type of person receiving the opioid 
5 antagonist (student, staff, or visitor);
6  (2) the location where symptoms developed;
7  (3) the type of person administering the opioid 
8 antagonist (school nurse or trained personnel); and
9  (4) any other information required by the State Board. 
10 (i-10) Within 3 days after the administration of 
11undesignated asthma medication by a school nurse, trained 
12personnel, or a student at a school or school-sponsored 
13activity, the school must report to the State Board of 
14Education, on a form and in a manner prescribed by the State 
15Board of Education, the following information:
16  (1) the age and type of person receiving the asthma 
17 medication (student, staff, or visitor);
18  (2) any previously known diagnosis of asthma for the 
19 person;
20  (3) the trigger that precipitated respiratory 
21 distress, if identifiable;
22  (4) the location of where the symptoms developed;
23  (5) the number of doses administered;
24  (6) the type of person administering the asthma 
25 medication (school nurse, trained personnel, or student);
26  (7) the outcome of the asthma medication 
 
 
HB3428- 20 -LRB103 29807 RJT 56214 b


1 administration; and
2  (8)
any other information required by the State Board. 
3 (j) By October 1, 2015 and every year thereafter, the 
4State Board of Education shall submit a report to the General 
5Assembly identifying the frequency and circumstances of 
6undesignated epinephrine and undesignated asthma medication 
7administration during the preceding academic year. Beginning 
8with the 2017 report, the report shall also contain 
9information on which school districts, public schools, charter 
10schools, and nonpublic schools maintain or have independent 
11contractors providing transportation to students who maintain 
12a supply of undesignated epinephrine injectors. This report 
13shall be published on the State Board's Internet website on 
14the date the report is delivered to the General Assembly.
15 (j-5) Annually, each school district, public school, 
16charter school, or nonpublic school shall request an asthma 
17action plan from the parents or guardians of a pupil with 
18asthma. If provided, the asthma action plan must be kept on 
19file in the office of the school nurse or, in the absence of a 
20school nurse, the school administrator. Copies of the asthma 
21action plan may be distributed to appropriate school staff who 
22interact with the pupil on a regular basis, and, if 
23applicable, may be attached to the pupil's federal Section 504 
24plan or individualized education program plan.
25 (j-10) To assist schools with emergency response 
26procedures for asthma, the State Board of Education, in 
 
 
HB3428- 21 -LRB103 29807 RJT 56214 b


1consultation with statewide professional organizations with 
2expertise in asthma management and a statewide organization 
3representing school administrators, shall develop a model 
4asthma episode emergency response protocol before September 1, 
52016. Each school district, charter school, and nonpublic 
6school shall adopt an asthma episode emergency response 
7protocol before January 1, 2017 that includes all of the 
8components of the State Board's model protocol.
9 (j-15) Every 2 years, school personnel who work with 
10pupils shall complete an in-person or online training program 
11on the management of asthma, the prevention of asthma 
12symptoms, and emergency response in the school setting. In 
13consultation with statewide professional organizations with 
14expertise in asthma management, the State Board of Education 
15shall make available resource materials for educating school 
16personnel about asthma and emergency response in the school 
17setting.
18 (j-20) On or before October 1, 2016 and every year 
19thereafter, the State Board of Education shall submit a report 
20to the General Assembly and the Department of Public Health 
21identifying the frequency and circumstances of opioid 
22antagonist administration during the preceding academic year. 
23This report shall be published on the State Board's Internet 
24website on the date the report is delivered to the General 
25Assembly. 
26 (k) The State Board of Education may adopt rules necessary 
 
 
HB3428- 22 -LRB103 29807 RJT 56214 b


1to implement this Section. 
2 (l) Nothing in this Section shall limit the amount of 
3epinephrine injectors that any type of school or student may 
4carry or maintain a supply of.
5(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21; 
6102-813, eff. 5-13-22.)